SCENIHR Recommends Phased Approach to Risk Evaluation of Nanomaterials

International Medical Device Regulatory Monitor
A A
Manufacturers of medical devices that contain nanomaterials should use a phased approach to evaluate risk to avoid unnecessary testing, an expert committee of the European Commission recommends.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00